{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:25:47Z","timestamp":1759047947214},"reference-count":42,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2007,4,1]]},"DOI":"10.1200\/jco.2006.10.2251","type":"journal-article","created":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T22:23:16Z","timestamp":1175293396000},"page":"1289-1291","source":"Crossref","is-referenced-by-count":19,"title":["CD57 Expression on Lymphoma Microenvironment As a New Prognostic Marker Related to Immune Dysfunction"],"prefix":"10.1200","volume":"25","author":[{"given":"Daniele","family":"Focosi","sequence":"first","affiliation":[{"name":"Division of Hematology, Azienda Ospedaliera Universitaria Santa Chiara, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Petrini","sequence":"additional","affiliation":[{"name":"Division of Hematology, Azienda Ospedaliera Universitaria Santa Chiara, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4766"},{"key":"R2","unstructured":"Atayar C, van den Berg A, Blokzijl T, et al: Hodgkin lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments. J Clin Pathol [epub ahead of print on December 8, 2006]"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1007\/BF03032360"},{"key":"R4","unstructured":"Leger-Ravet M, Devergne O, Peuchmaur M: In situ detection of activated cytotoxic ceils in follicular lymphomas. Am J Pathol 144:492,1994-499,"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309148509"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2103"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.8.5145"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Tarazona R, DelaRosa O, Alonso C, et al: Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector\/senescent T cells. Mech Ageing Dev 121:77,2000-88,","DOI":"10.1016\/S0047-6374(00)00199-8"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/S0047-6374(97)00161-9"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.3.555"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V66.1.64.64"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(86)90135-2"},{"key":"R13","unstructured":"Fateminasab F, Shahgasempour S, Mirsaeidi S, et al: Increased activation and expansion of a CD57+ subset within peripheral CD8+ T lymphocytes in Mycobacterium tuberculosis-infected patients. Arch Iran Med 9:53,2006-57,"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.08.011"},{"key":"R15","unstructured":"Stricker R, Burrascano J, Winger E: Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. Ann Agric Environ Med 9:111,2002-113,"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(00)00316-3"},{"key":"R17","unstructured":"Aronsson B, Troye-Blomberg M, Smedman L: Increase of circulating CD8+CD57+ lymphocytes after measles infection but not after measles vaccination. J Clin Lab Immunol 53:1,2004-12,2005"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020343"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-006-9035-1"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1354.009"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200304000-00017"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.10.2237.2237"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2002.tb00201.x"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000100396.81490.0C"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Mollet L, Sadat-Sowti B, Duntze J, et al: CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int. Immunol 10:311,1998-323,","DOI":"10.1093\/intimm\/10.3.311"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Morley J, Batliwalla F, Hingorani R, et al: Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset. J Immunol 154:6182,1995-6190,","DOI":"10.4049\/jimmunol.154.11.6182"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00901.x"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.587.587"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/S0047-6374(00)00240-2"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/S0531-5565(03)00134-7"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024580531705"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2003.11.016"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/S0047-6374(03)00026-5"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.12.7481"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00309-8"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.3109\/00365549709035891"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-004-0525-9"},{"key":"R38","unstructured":"Characiejus D, Pasukoniene V, Kazlauskaite N, et al: Predictive value of CD8high CD57+ lymphocyte subset in interferon therapy of patients with renal cell carcinoma. Anticancer Res 22:3679,2002-3683,"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041869"},{"key":"R40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1565"},{"key":"R41","doi-asserted-by":"crossref","unstructured":"Canioni D, Salles G, Mounier N, et al: The poor prognosis value of high intra-tumoral macrophages counts in follicular lymphoma patients requires selection of appropriate cut-off and can be circumvented by rituximab therapy. Blood 822,2006,","DOI":"10.1182\/blood.V108.11.822.822"},{"key":"R42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-018218"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2006.10.2251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T07:13:06Z","timestamp":1683789186000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2006.10.2251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,1]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,4,1]]}},"alternative-id":["10.1200\/JCO.2006.10.2251"],"URL":"https:\/\/doi.org\/10.1200\/jco.2006.10.2251","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,1]]}}}